- Development Milestone
• 2015 The civil (building) construction work of The New International Finished
Drug Formulation Center has been completed
• 2013 Established Xinhua Pharmaceutical (U.S.) Co., Ltd.
• 2011 Solid Dosage plant (No.206) was approved by UK MHRA
• 2010 Hutian Site was established (for innovative
• 2009 FDF CMO Project with UK Partner Triggered
• 2008 Shouguang Site is established.
• 2007 Contract project for finished dosage with Bayer Healthcare
• 2003 Xinhua Pharmaceutical (European) GmbH was established.
• 2003 The JV between Xinhua and Perrigo was established.
• 1998 The Contract Project with Sankyo Chemical for two
• 1997 Listed in Shenzhen stock exchange.
• 1996 Listed in Hong Kong stock exchange.
• 1994 The J.V. between Shandong Xinhua And DSM was
• 1993 The J.V. between Shandong Xinhua And Harvest Trading
GmbH was established.
• 1980 The first company in China to produce Salicylic Acid by
Introducing the equipment from Sweden.
• 1970 The first company in China to produce bulk Ibuprofen.
• 1959 The first company in China to produce bulk Acetyl Salicylic
• Acid and Caffeine.
• 1954 China’s the first API production line was started in Xinhua.
• 1953 Developed the first glass-lined reactor in China.
• 1950 Succeeded in developing sodium stibogluconate for stamping
the Kala-Azar which was the epidemic lasted several
decades in China.
• 1943 Founded in 1943.